Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Langerhorst

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Iscience|September 2, 2025
Targeting synergetic endothelial inflammation by inhibiting NFKB and JAK-STAT pathwaysStijn A Groten, Pieter Langerhorst, Georgios Malamas, et al.
Clinical Chemistry|September 14, 2022
Precipitating PlasmaRemy J H Martens, Joannes F M Jacobs, Pieter Langerhorst, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2026
A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMT S13 in immune-mediated thrombotic thrombocytopenic purpuraMargot Dierickx, Stijn Groten, Mariarosaria Miranda, et al.
Journal of Proteome Research|October 22, 2025
Considering Measurement Time and Depth in diaPASEF Plasma ProteomicsEva R Smit, Carmen van der Zwaan, Stijn A Groten, et al.
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2023
Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpuraTim Postmus, Nuno A G Graça, Juliana Ferreira de Santana, et al.
International Journal of Molecular Sciences|February 11, 2023
Glycoproteomics in Cerebrospinal Fluid Reveals Brain-Specific Glycosylation ChangesMelissa Baerenfaenger, Merel A Post, Pieter Langerhorst, et al.
Molecular Omics|December 8, 2021
Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myelomaEsther A Zaal, Harm-Jan de Grooth, Inge Oudaert, et al.
Clinical Chemistry|March 12, 2021
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple MyelomaPieter Langerhorst, Arie B Brinkman, Martijn M VanDuijn, et al.
Clinical Chemistry|October 13, 2021
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone MarrowPieter Langerhorst, Somayya Noori, Marina Zajec, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Iscience|September 2, 2025
Targeting synergetic endothelial inflammation by inhibiting NFKB and JAK-STAT pathwaysStijn A Groten, Pieter Langerhorst, Georgios Malamas, et al.
Clinical Chemistry|September 14, 2022
Precipitating PlasmaRemy J H Martens, Joannes F M Jacobs, Pieter Langerhorst, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2026
A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMT S13 in immune-mediated thrombotic thrombocytopenic purpuraMargot Dierickx, Stijn Groten, Mariarosaria Miranda, et al.
Journal of Proteome Research|October 22, 2025
Considering Measurement Time and Depth in diaPASEF Plasma ProteomicsEva R Smit, Carmen van der Zwaan, Stijn A Groten, et al.
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2023
Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpuraTim Postmus, Nuno A G Graça, Juliana Ferreira de Santana, et al.
International Journal of Molecular Sciences|February 11, 2023
Glycoproteomics in Cerebrospinal Fluid Reveals Brain-Specific Glycosylation ChangesMelissa Baerenfaenger, Merel A Post, Pieter Langerhorst, et al.
Molecular Omics|December 8, 2021
Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myelomaEsther A Zaal, Harm-Jan de Grooth, Inge Oudaert, et al.
Clinical Chemistry|March 12, 2021
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple MyelomaPieter Langerhorst, Arie B Brinkman, Martijn M VanDuijn, et al.
Clinical Chemistry|October 13, 2021
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone MarrowPieter Langerhorst, Somayya Noori, Marina Zajec, et al.
Pageof 2